Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: J Tissue Eng Regen Med. 2014 Apr 16;10(12):1041–1056. doi: 10.1002/term.1889

Table 2.

Size and surface charge of DOX-encapsulated PLGA NPs, formulated with 0.25 % w/v PVA as the surfactant/stabilizer. (n = 6, mean ± S.D).

Blank NPs DOX loading [%; w/w ratio to PLGA]
Agent-free 2 5
Size [nm] 386.8 ± 46.5 343.8 ± 5.3 342.3 ± 1.4
ζ-potential [mV] -30.3 ± 2.3 -28.2 ± 1.0 -31.6 ± 1.0
Encapsulation efficiency [%] N/A 58.3 ± 0.5 57.9 ± 0.9